Healthcare Global Diabetes Devices and Services Growth Opportunities

Growth Strategies in an Increasingly Competitive and Digitalized Environment

INDUSTRY
Healthcare

RELEASE DATE
06-Jan-2022
REGION
Global
DELIVERABLE TYPE
Market Research

RESEARCH CODE
K6D9-01-00-00-00
SKU
HC03489-GL-MT_26161
Yes
SHARE

Global Diabetes Devices and Services Growth Opportunities
Published on: 06-Jan-2022 | SKU: HC03489-GL-MT_26161

Need more details?

$2,450.00

$1,837.50 save 25 %

DownloadLink
Need more details?

The diabetes industry offers significant growth opportunities, given the rising prevalence of this disease condition. However, the devices space comprising self-monitoring of blood glucose (SMBG, or glucometer), continuous glucose monitors (CGMs), insulin pens, and insulin pumps are facing unprecedented threats and challenges, some of which are definitely opportunities in disguise. These are in the form of business dynamics (including competitor advances), emerging disease management approaches, technology advances, and also Mega Trends driven by the pandemic. For each diabetes device manufacturer planning their short-term (1 to 3 year) and long-term (5 to 7 year) strategies, this study offers insights into what their peers within the same and adjacent device category are aiming for, how the pharmaceutical industry is impacting the diabetes space, the emerging disease management approaches and trends of virtual care, and how to target the huge emerging market potential, which remains unacknowledged and untapped. It also highlights the direction of the industry for each device type in the developed markets, allowing strategies to be aligned to market growth and avoiding competitive losses.

Author: Siddharth Shah

Why is it Increasingly Difficult to Grow?

The Strategic Imperative 8™

The Impact of the Top Three Strategic Imperatives on Diabetes Devices and Services

Growth Opportunities Fuel the Growth Pipeline Engine™

Segmentation

Growth Drivers

Growth Restraints

Overview of Opportunities and Threats

Trends and Threats for SMBG Participants

Trends and Threats for CGM Device Vendors

Trends and Threats for Insulin Pen Vendors

Trends and Threats for Insulin Pump Vendors

Summarized Insights

Summarized Insights (continued)

Select Trends of Focus

Pharma Participants Pushing Diabetes Management Solutions

New Business Models

Diabetes Start-up Acquisitions

Rising PE & VC Investment in Diabetes

Pivot to Diabetes Disease Management

Rise in Digital Diabetes ‘Reversal’ Management Solutions’ Adoption

Non-invasive Monitoring Tech and Wearables Emerging

Emerging Diabetes ‘Treatment’ Approaches

Global Diabetes Prevalence

Rise in Pre-diabetes and Diabetes Prevalence

Regional Distribution of Diabetics

Changes in Regional Share of Diabetics

Pre-diabetes—Another Cause for Concern

Target Regions for Diabetes & Pre-Diabetes Management

Care Models to Target Emerging Markets

India—Premium Offerings in a Large, Out-of-pocket Market

Africa’s Unique Needs Demand a Different Approach

Dubai’s Glucare—Integrated Care Model

Sector-wise Growth Strategies in Developed Markets

Sector-wise Growth Strategies in Developed Markets (continued)

Evolution of Approaches to Manage Chronic Condition Patients

Growth Opportunity 1—Active Disease Management Vendor Partnerships for Tapping Unaddressed Market Needs

Growth Opportunity 1—Active Disease Management Vendor Partnerships for Tapping Unaddressed Market Needs (continued)

Growth Opportunity 2—Enabling Digital Platforms for Diabetic’s Data Collection & Insights

Growth Opportunity 2—Enabling Digital Platforms for Diabetic’s Data Collection & Insights (continued)

Growth Opportunity 3—Developing Type 1 Diabetes-specific Disease Management Solutions with Insulin Pumps to Prepare for Competition

Growth Opportunity 3—Developing Type 1 Diabetes-specific Disease Management Solutions with Insulin Pumps to Prepare for Competition (continued)

Growth Opportunity 4—Targeting Wellness Applications for Non-Diabetics

Growth Opportunity 4—Targeting Wellness Applications for Non-Diabetics (continued)

Growth Opportunity 5—Tap Emerging Markets for Next Phase of Growth

Growth Opportunity 5—Tap Emerging Markets for Next Phase of Growth (continued)

List of Exhibits

List of Exhibits (continued)

Legal Disclaimer

List of Figures
  • Diabetes Devices and Services: Market Segmentation, Global, 2021
  • Diabetes Devices and Services: Growth Drivers, Global, 2022–2026
  • Diabetes Devices and Services: Growth Restraints, Global, 2022–2026
  • Diabetes Devices and Services: Trends & Threats for SMBG Device OEMs, Global, 2021–2028
  • Diabetes Devices and Services: Trends & Threats for CGM Device OEMs, Global, 2021–2028
  • Diabetes Devices and Services: Trends & Threats for Insulin Pen Device OEMs, Global, 2021–2028
  • Diabetes Devices and Services: Trends & Threats for Insulin Pump Device OEMs, Global, 2021–2028
  • Diabetes Devices and Services: Summary of Market Trends by Device Type, Global, 2021
  • Diabetes Devices and Services: Select Diabetes Acquisitions, Global, 2020–October 2021
  • Diabetes Devices and Services: Funding for Diabetes Start-ups, US, 2018–H1 2021
  • Diabetes Devices and Services: The Digital Care Model for Diabetes Management, Global, 2021
  • Diabetes Devices and Services: Non-invasive Glucose Measurement Start-ups’ Progress, Global, 2021
  • Diabetes Devices and Services: Diabetes Prevalence, Global, 2000–2019
  • Diabetes Devices and Services: Estimates of Diabetes Prevalence, Global, 2025, 2030, and 2045
  • Diabetes Devices and Services: Pre-diabetes and Diabetes Prevalence Growth, Global, 2019-2045
  • Diabetes Devices and Services: Diabetes Prevalence by Region with Proportion of Undiagnosed Patients, Global, 2019
  • Diabetes Devices and Services: Changes in Diabetes Prevalence by Region, Global, 2019 and 2045
  • Diabetes Devices and Services: Pre-diabetes Prevalence by Region, Global, 2019–2045
  • Diabetes Devices and Services: Target Regions for Diabetes and Pre-diabetes Management Growth, Global, 2019 and 2045
  • Diabetes Devices and Services: Target Channels and Solutions for Diabetes Services, Emerging Markets, 2021

Have questions about this research or need deeper insights?
Speak directly with our analytics experts for tailored recommendations.

Recent related Healthcare research

15 Sep 2026   |   Global   |   Market Research

Vendor Profiles: Advanced Wound Care Management Market, Global, 2025

The wound care market is being transformed by advanced technologies and evolving care models that focus on improving patient outcomes and reducing healthcare costs. Innovations such as smart sensor-embedded dressings, artificial intelligence (AI)-based wound imaging systems, enhanced negative pressu...

11 Sep 2026   |   Global   |   Frost Radar

Frost Radar™: Pharmaceutical Commercialization Solutions and Services, 2026

Pharmaceutical commercialization is a multidimensional concept in the successful launch and distribution of a drug. The process includes the development of a pricing strategy that reflects the drug’s value, negotiation with payers to ensure drug cost coverage, regulatory compliance, and the generati...

07 Sep 2026   |   Global   |   Technology Research

Synthetic Antibodies and AI-Optimized Immunotherapies

Artificial intelligence is becoming increasingly relevant to antibody discovery and immunotherapy development, supporting target identification, de novo antibody design, antibody engineering, clinical intelligence, and bioprocessing. Advances in generative AI, protein language models, diffusion mode...

28 Aug 2026   |   Global   |   Technology Research

Innovations and Growth Opportunities in Advanced Medical Devices, Artificial Intelligence Solutions, Digital Solutions, and Medical Imaging Solutions

The latest issue of Advanced MedTech Technology Opportunity Engine (TOE) spotlights a diverse slate of innovations across advanced medical devices, artificial intelligence solutions, digital solutions, and medical imaging solutions.The issue features advanced medical devices such as active bioelectr...

27 Aug 2026   |   Global   |   Frost Radar

Frost Radar: AI-Powered Molecular Diagnostics, 2026

AI-powered molecular diagnostics is an emerging and moderately fragmented industry that includes molecular diagnostics companies, precision medicine platforms, sequencing specialists, AI-driven analytics providers, and disease-focused biotechnology companies. No single company has dominated, present...

 

Purchase includes:
  • Report download
  • Growth Dialog™ with our experts

Growth Dialog™

A tailored session with you where we identify the:
  • Strategic Imperatives
  • Growth Opportunities
  • Best Practices
  • Companies to Action

Impacting your company's future growth potential.

The diabetes industry offers significant growth opportunities, given the rising prevalence of this disease condition. However, the devices space comprising self-monitoring of blood glucose (SMBG, or glucometer), continuous glucose monitors (CGMs), insulin pens, and insulin pumps are facing unprecedented threats and challenges, some of which are definitely opportunities in disguise. These are in the form of business dynamics (including competitor advances), emerging disease management approaches, technology advances, and also Mega Trends driven by the pandemic. For each diabetes device manufacturer planning their short-term (1 to 3 year) and long-term (5 to 7 year) strategies, this study offers insights into what their peers within the same and adjacent device category are aiming for, how the pharmaceutical industry is impacting the diabetes space, the emerging disease management approaches and trends of virtual care, and how to target the huge emerging market potential, which remains unacknowledged and untapped. It also highlights the direction of the industry for each device type in the developed markets, allowing strategies to be aligned to market growth and avoiding competitive losses. Author: Siddharth Shah
More Information
Deliverable Type Market Research
No Index No
Podcast No
List of Charts and Figures Diabetes Devices and Services: Market Segmentation, Global, 2021~ Diabetes Devices and Services: Growth Drivers, Global, 2022–2026~ Diabetes Devices and Services: Growth Restraints, Global, 2022–2026~ Diabetes Devices and Services: Trends & Threats for SMBG Device OEMs, Global, 2021–2028~ Diabetes Devices and Services: Trends & Threats for CGM Device OEMs, Global, 2021–2028~ Diabetes Devices and Services: Trends & Threats for Insulin Pen Device OEMs, Global, 2021–2028~ Diabetes Devices and Services: Trends & Threats for Insulin Pump Device OEMs, Global, 2021–2028~ Diabetes Devices and Services: Summary of Market Trends by Device Type, Global, 2021~ Diabetes Devices and Services: Select Diabetes Acquisitions, Global, 2020–October 2021~ Diabetes Devices and Services: Funding for Diabetes Start-ups, US, 2018–H1 2021~ Diabetes Devices and Services: The Digital Care Model for Diabetes Management, Global, 2021~ Diabetes Devices and Services: Non-invasive Glucose Measurement Start-ups’ Progress, Global, 2021~ Diabetes Devices and Services: Diabetes Prevalence, Global, 2000–2019~ Diabetes Devices and Services: Estimates of Diabetes Prevalence, Global, 2025, 2030, and 2045~ Diabetes Devices and Services: Pre-diabetes and Diabetes Prevalence Growth, Global, 2019-2045~ Diabetes Devices and Services: Diabetes Prevalence by Region with Proportion of Undiagnosed Patients, Global, 2019~ Diabetes Devices and Services: Changes in Diabetes Prevalence by Region, Global, 2019 and 2045~ Diabetes Devices and Services: Pre-diabetes Prevalence by Region, Global, 2019–2045~ Diabetes Devices and Services: Target Regions for Diabetes and Pre-diabetes Management Growth, Global, 2019 and 2045~ Diabetes Devices and Services: Target Channels and Solutions for Diabetes Services, Emerging Markets, 2021~
Author Siddharth Shah
Industries Healthcare
WIP Number K6D9-01-00-00-00
Is Prebook No
GPS Codes 9600-B1,9A4B-B1

Global Diabetes Devices and Services Growth Opportunities

$2,450.00

Special Price $1,837.50 save 25 %

In stock
SKU
HC03489-GL-MT_26161